艾裏德克斯 IRIX 深 滬
已收盤 02-06 16:00:00 美东时间
1.46
+0.030
+2.10%
華盛通- 最 高1.5099
- 今 開1.48
- 成交量 3.02万股
- 最 低 1.43
- 昨 收 1.43
- 總市值 2509.74万
- 52周最高 1.6481
- 市盈率 靜 --
- 換手率 0.18%
- 52周最低 0.782
- 委 比 41.68%
- 總股本 1719.00万
- 歷史最高 16.64
- 量 比 0.30
- 振 幅 5.59%
- 歷史最低 0.782
- 每 手 1
- 風險率 0.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多IRIDEX CFO Romeo R. Dizon Reports Acquisition of Common Shares
IRIDEX CFO Romeo R. Dizon Reports Acquisition of Common Shares Romeo R. Dizon, Chief Financial Officer of IRIDEX Corporation, reported the acquisition of common shares of IRIDEX Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Tec
02-04 07:21
IRIDEX Corporation Plans Headquarters Move to San Jose
IRIDEX Corporation Plans Headquarters Move to San Jose IRIDEX Corporation has announced plans to relocate its headquarters from Mountain View, California to San Jose. The move is expected to generate approximately $0.4 million in savings in fiscal year 2026 and $0.6 million annually thereafter, as p
02-02 20:00
Iridex Announces Plans to Relocate Headquarters
Iridex Corporation announced its plan to relocate its headquarters from Mountain View to San Jose, California, aiming to generate cost savings of $0.4 million in FY 2026 and $0.6 million annually thereafter. Patrick Mercer, CEO, highlighted the move as another step in reducing operating expenses while maintaining operations and attracting talent in the Bay Area. The company expects the relocation to support its strategy of cutting costs.
02-02 12:00
IRIDEX CFO Romeo R. Dizon Acquires Common Shares
IRIDEX CFO Romeo R. Dizon Acquires Common Shares Romeo R. Dizon, Chief Financial Officer of IRIDEX Corporation, has reported the acquisition of common shares of IRIDEX Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies
01-22 03:10
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
Iridex Corporation reported strong financial performance in Q4 2025 and the full year, with revenue growing 15-17% YoY in Q4 to $14.6-$14.8M and 8% YoY for the year to $52.5-$52.7M. The company achieved positive cash flow in Q4 and expects positive adjusted EBITDA for 2025. Cyclo G6 probe sales reached 57,700 units annually, up 4% YoY, while laser system sales rose to 133 units. CEO Patrick Mercer highlighted cost reductions, operational efficien...
01-12 12:00
New Study Shows Iridex Laser Treatment Safely Lowers Eye Pressure for Glaucoma Patients
Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a
2025-12-11 20:07
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
Iridex Corporation announced its participation in the Sidoti Year-End Virtual Investor Conference, with management scheduled to present on December 11 at 10:45 am ET. The presentation will be accessible live and archived via the company’s website. Iridex, a global leader in laser-based medical systems for ophthalmology, utilizes its proprietary MicroPulse® technology to treat glaucoma and retinal diseases. For more information, visit www.iridex.c...
2025-12-05 12:00
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 176.6% to $1.21...
2025-11-13 01:05
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Shares of LightPath Technologies Inc (NASDAQ:LPTH) rose sharply in pre-market t...
2025-11-12 17:42
IRIDEX shares are trading lower. The company reported Q3 financial results.
IRIDEX shares are trading lower. The company reported Q3 financial results.
2025-11-12 05:13
